Skip to main content
SpringerLink
Log in

Invasive aspergillosis in the ICU: an emerging disease

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes ARJ, Groeneveld ABJ (2007) Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med (DOI 10.1007/s00134-007-0791-z)

  2. Segal BH, Walsh TJ (2006) Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 173:707–717

    Article  PubMed  CAS  Google Scholar 

  3. Patterson TF (2005) Advances and challenges in management of invasive mycoses. Lancet 366:1013–1025

    Article  PubMed  Google Scholar 

  4. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E (2004) Invasive aspergillosis in critically III patients without malignancy. Am J Respir Crit Care Med 170:621–625

    Article  PubMed  Google Scholar 

  5. Vandewoude KH, Blot S, Depuydt P, Benoit D, Temmerman W, Colardyn F, Vogelaers D (2006) Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31

    Article  PubMed  Google Scholar 

  6. Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, Leon C, Alvarez-Lerma F, Nolla-Salas J, Iruretagoyena J, Barcenilla F (2005) Isolation of Aspergillus spp from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 9:R191–R199

    Article  PubMed  Google Scholar 

  7. Hartemink KJ, Paul MA, Spijkstra JJ, Girbes AR, Polderman KH (2003) Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 29:2068–2071

    Article  PubMed  Google Scholar 

  8. Vandewoude KH, Vogelaers D (2007) Medical imaging and timely diagnosis of invasive pulmonary aspergillosis. Clin Infect Dis 44:380–381

    Article  PubMed  Google Scholar 

  9. Perfect JR, Cox GM, Lee JY Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA, Mycoses Study Group (2001) The impact of culture isolation of aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33:1824–1833

    Article  PubMed  CAS  Google Scholar 

  10. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882–885

    Article  PubMed  CAS  Google Scholar 

  11. Kwak EJ, Husain S, Obman A, Meinke L, Stout J, Kusne S, Wagener M, Singh N (2004) Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol 42:435–438

    Article  PubMed  Google Scholar 

  12. Husain S, Kwak EJ, Obman A, Wagener M, Kusne S, Stout J, McCurry K, Singh N (2004) Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transpl 4:796–802

    Article  Google Scholar 

  13. Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N (2007) Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 83:1330–1336

    Article  PubMed  CAS  Google Scholar 

  14. Sulahian A, Touratier S, Ribaud P (2003) False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 349:2366–2377

    Article  PubMed  CAS  Google Scholar 

  15. Surmont I, Stockman W (2007) Gluconate-containing solutions: another cause of false-positive galactomannan assay reactivity. J Clin Microbiol 45:1373

    Article  PubMed  Google Scholar 

  16. Denning DW (2003) Echinocandin antifungal drugs. Lancet 362:1142–1151

    Article  PubMed  CAS  Google Scholar 

  17. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer, The Global Aspergillus Study Group (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Intensive Care Unit and Infectious Diseases Unit, Department of General Internal Medicine, University Hospital, Herestraat 49, 3000, Leuven, Belgium

    Wouter Meersseman & Eric Van Wijngaerden

Authors
  1. Wouter Meersseman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Van Wijngaerden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wouter Meersseman.

Additional information

This editorial refers to the article available at: http://dx.doi.org/10.1007/s00134-007-0791-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meersseman, W., Van Wijngaerden, E. Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med 33, 1679–1681 (2007). https://doi.org/10.1007/s00134-007-0792-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-007-0792-y

Search

Navigation